BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1921263)

  • 1. Inhibition of cellular proliferation in human T lyophotropic virus type I (HTLV-I)-infected T cells from patients with HAM by steroid hormones and cyclosporin A.
    Yamada H; Nakao Y; Fujita T
    Kobe J Med Sci; 1991 Apr; 37(2):57-79. PubMed ID: 1921263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 1 alpha,25-dihydroxyvitamin D3 on proliferation of activated T-cells and established human lymphotropic virus type I-positive T-cell lines.
    Nakao Y; Koizumi T; Matsui T; Matsuda S; Nakagawa T; Katakami Y; Fujita T; Maeda S; Morikawa S; Ito Y
    J Natl Cancer Inst; 1987 Jun; 78(6):1079-86. PubMed ID: 2884343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid syncytium formation between human T-cell leukaemia virus type-I (HTLV-I)-infected T-cells and human nervous system cells: a possible implication for tropical spastic paraparesis/HTLV-I associated myelopathy.
    Mor-Vaknin N; Turgeman H; Torgeman A; Wolfson M; Huleihel M; Aboud M
    Cell Biol Int; 1998; 22(2):95-103. PubMed ID: 9878096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTLV-I production based on activation of integrin/ligand signaling in HTLV-I-infected T cell lines derived from HAM/TSP patients.
    Fukushima N; Nakamura T; Nishiura Y; Ida H; Aramaki T; Eguchi K
    Intervirology; 2008; 51(2):123-9. PubMed ID: 18552504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor.
    Azimi N; Jacobson S; Leist T; Waldmann TA
    J Immunol; 1999 Oct; 163(7):4064-72. PubMed ID: 10491011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
    Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
    J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.
    Nagai M; Kubota R; Greten TF; Schneck JP; Leist TP; Jacobson S
    J Infect Dis; 2001 Jan; 183(2):197-205. PubMed ID: 11120926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FK506 and cyclosporin a regulate proliferation and proto-oncogene expression in HTLV-1-associated myelopathy/tropical-spastic-paraparesis-derived T cells.
    Natazuka T; Umemiya-Okada T; Matsui T; Saida T; Nakao Y
    Int J Cancer; 1993 May; 54(2):348-54. PubMed ID: 7683633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TCGF(IL 2)-receptor inducing factor(s). II. Possible role of ATL-derived factor (ADF) on constitutive IL 2 receptor expression of HTLV-I(+) T cell lines.
    Okada M; Maeda M; Tagaya Y; Taniguchi Y; Teshigawara K; Yoshiki T; Diamantstein T; Smith KA; Uchiyama T; Honjo T
    J Immunol; 1985 Dec; 135(6):3995-4003. PubMed ID: 2999237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and regulation of the leukemia inhibitory factor/D factor gene in human T-cell leukemia virus type 1 infected T-cell lines.
    Umemiya-Okada T; Natazuka T; Matsui T; Ito M; Taniguchi T; Nakao Y
    Cancer Res; 1992 Dec; 52(24):6961-5. PubMed ID: 1458488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression.
    Teshigawara K; Maeda M; Nishino K; Nikaido T; Uchiyama T; Tsudo M; Wano Y; Yodoi J
    J Mol Cell Immunol; 1985; 2(1):17-26. PubMed ID: 2978223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of IL-10- and IFN-gamma-producing T-cell responses by autoreactive T-cells expressing human T-cell leukemia virus type I Tax.
    Takatsuka N; Hasegawa A; Takamori A; Shimizu Y; Kato H; Ohashi T; Amagasa T; Masuda T; Kannagi M
    Int Immunol; 2009 Sep; 21(9):1089-100. PubMed ID: 19654198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different cytokine production in tax-expressing cells between patients with human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis and asymptomatic HTLV-I carriers.
    Furukawa Y; Saito M; Matsumoto W; Usuku K; Tanaka Y; Izumo S; Osame M
    J Infect Dis; 2003 Apr; 187(7):1116-25. PubMed ID: 12660926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
    Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y
    Cancer Res; 1994 Jan; 54(2):592-7. PubMed ID: 8275499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-6 production by human T lymphocytes. Expression in HTLV-1-infected but not in normal T cells.
    Villiger PM; Cronin MT; Amenomori T; Wachsman W; Lotz M
    J Immunol; 1991 Jan; 146(2):550-9. PubMed ID: 1987276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic inhibitory effect of cyclosporin A and vitamin D derivatives on T-lymphocyte proliferation in active ulcerative colitis.
    Stio M; Treves C; Celli A; Tarantino O; d'Albasio G; Bonanomi AG
    Am J Gastroenterol; 2002 Mar; 97(3):679-89. PubMed ID: 11922564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of AP-2-binding activity in cell lines infected with human T-cell leukemia virus type I: possible enhancement of AP-2 binding by human T-cell leukemia virus type I tax.
    Mori N; Prager D
    Cancer Res; 1996 Feb; 56(4):779-82. PubMed ID: 8631013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of transcription of lck (lymphocyte specific protein tyrosine kinase) message in IL-2-independent, HTLV-I-transformed T cell lines.
    Koga Y; Oh-Hori N; Sato H; Yamamoto N; Kimura G; Nomoto K
    J Immunol; 1989 Jun; 142(12):4493-9. PubMed ID: 2786034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia.
    Sherman MP; Dube S; Spicer TP; Kane TD; Love JL; Saksena NK; Iannone R; Gibbs CJ; Yanagihara R; Dube DK
    Cancer Res; 1993 Dec; 53(24):6067-73. PubMed ID: 8261424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human T lymphotropic virus type I (HTLV-I)-specific T helper cell responses from HTLV-I seronegative patients with chronic myelopathy and MS in Japan.
    Nishimura M; Jacobson S; Uchiyama T; Ohta M; Saida T
    Mult Scler; 1996 Feb; 1(4):200-3. PubMed ID: 9345434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.